Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
8.77
+0.22 (2.57%)
Aug 4, 2026, 4:00 PM EDT - Market closed
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $79.02 million as of August 4, 2026. Its market cap has increased by 14.69% in one year.
Market Cap
79.02M
Enterprise Value
80.75M
1-Year Change
14.69%
Ranking
Category
Stock Price
$8.77
ChartMarket Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $79.02M, a decrease of -63.30%. That is a compound annual growth rate of -8.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 79.00M | -39.42% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 85.32M |
| Alterity Therapeutics | 85.24M |
| Rallybio | 84.56M |
| MAIA Biotechnology | 82.69M |
| Annovis Bio | 79.55M |
| Telomir Pharmaceuticals | 79.09M |
| Champions Oncology | 75.72M |
| Gain Therapeutics | 75.07M |